Tax Dodger Apple Te...
Health Care: Drugs
Corcept Therapeutics Inc. (CORT: NASDAQ)
$1.79 0.03 | 1.70%
05/21/13 - 12:35 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 3.31M | 0.00 | 0.00 | 29.00K |
| Cost of Sales | 91.00K | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 3.22M | 0.00 | 0.00 | 29.00K |
| Selling, General, and Administrative Expenses | 25.41M | 11.33M | 8.49M | 5.88M |
| Research & Development | 14.07M | 21.00M | 18.95M | 14.40M |
| Operating Income before D & A (EBITDA) | -36.27M | -32.33M | -27.44M | -20.25M |
| Depreciation & Amortization | 1.72M | 3.00K | 6.00K | 10.00K |
| Interest Income | 0.00 | 3.00K | 1.50M | 101.00K |
| Other Income - Net | 0.00 | -25.00K | -25.00K | -17.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -38.00M | -32.36M | -25.97M | -20.18M |
| Interest Expense | 1.78M | 0.00 | 0.00 | 0.00 |
| Pre-Tax Income | -39.77M | -32.36M | -25.97M | -20.18M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -38.05M | 0.00 | 0.00 | 0.00 |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -38.05M | 0.00 | 0.00 | 0.00 |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -38.05M | -32.35M | -25.97M | -20.17M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-38.05M | 0.00 | 0.00 | 0.00 |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -38.05M | 0.00 | 0.00 | 0.00 |
| Basic EPS from Continuing Ops. | -0.41 | -0.39 | -0.38 | -0.38 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.41 | -0.39 | -0.38 | -0.38 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.41 | -0.39 | -0.38 | -0.38 |
| Basic Normalized Net Income/Share | -0.41 | n.a. | n.a. | n.a. |
| EPS fr Continuing Ops. | -0.41 | -0.39 | -0.38 | -0.38 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.41 | -0.39 | -0.38 | -0.38 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.41 | -0.39 | -0.38 | -0.38 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.41 | n.a. | n.a. | n.a. |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with CORT
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
Latest CORT Headlines from TheStreet
- 5 Stocks Setting Up to Break Out 01.25.13 | 01:01 pm
- 3 Stocks Under $2 Spiking Higher 01.03.13 | 03:01 pm
- Short Sellers Are More Bullish About These Hedge Fund Favorites 12.20.12 | 04:12 pm
- 5 Stocks Insiders Are Snapping Up 11.28.12 | 12:11 pm
- Corcept Has Upside Following Drug Approval 02.21.12 | 12:02 pm
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- These Drugs Stocks Will Win FDA Approval 02.16.12 | 12:02 pm
- Biotech Stock Mailbag: Corcept Therapeutics, Reader Retorts 02.10.12 | 07:02 am
- Play TheStreet's FDA Drug-Approval Contest 01.23.12 | 08:01 am
- 27 Hot Drugs Facing FDA Approval in 2012 12.19.11 | 10:12 am
Press Releases for CORT
- Behind The Success - Research Report On Corcept Therapeutics Inc. And Dyax Corp. - PR Newswire 01.23.13 | 08:01 am
Partner Headlines for CORT
- 2 $2 Biotech Stocks Insiders Are Buying - Seeking Alpha 03.01.13 | 09:03 am
- 3 Liquid Biotech Stocks With Impressive Growth Projections - Seeking Alpha 08.12.12 | 09:08 am
- Facebook and Nasdaq STILL BATTLING and 3 Headlines Investors are Watching Now - Wall St. Cheat Sheet 07.02.12 | 12:07 pm
- Company News for February 22, 2012 - Corporate Summary - Zacks 02.22.12 | 10:02 am
- UPDATE: Stifel Nicolaus Increases Target to $9 on Concept Therepeutics - Benzinga 02.21.12 | 09:02 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
- 14 Oversold Stocks With Bearish Options - Seeking Alpha 07.01.11 | 08:07 am
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- 7 Small-Cap Biotechs With Bullish Insider Buying in 2011 - Seeking Alpha 06.12.11 | 05:06 am
